CompaniesGadeta

Gadeta

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

26

By Phase

PHASE1: 1

By Status

UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
Today
NCT04688853
Hover over trial bars to see details

Recent Trials

NCT04688853Lead Sponsor
A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients
PHASE1Unknown
26 participants
Started: May 13, 2021 · Completed: Jul 30, 2024
Related Companies
Clade Therapeutics
acquired